These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 28195943)

  • 1. Confused and Too Long: Neurotoxicity and Cardiac Toxicity of Flecainide.
    Tsai TF; Garcia RT; Bui JQ; Thinda A; Amsterdam EA
    Crit Pathw Cardiol; 2017 Mar; 16(1):42-45. PubMed ID: 28195943
    [No Abstract]   [Full Text] [Related]  

  • 2. Safety of flecainide versus propafenone for the long-term management of symptomatic paroxysmal supraventricular tachyarrhythmias. Report from the Flecainide and Propafenone Italian Study (FAPIS) Group.
    Chimienti M; Cullen MT; Casadei G
    Eur Heart J; 1995 Dec; 16(12):1943-51. PubMed ID: 8682031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flecainide toxicity--treatment with intravenous fat emulsion and extra corporeal life support.
    Sivalingam SK; Gadiraju VT; Hariharan MV; Atreya AR; Flack JE; Aziz H
    Acute Card Care; 2013 Dec; 15(4):90-2. PubMed ID: 24200150
    [No Abstract]   [Full Text] [Related]  

  • 4. A misguided 'pill in the pocket' approach with flecainide leading to cardiac arrest.
    Kiblboeck D; Braeuer-Mocker M; Siostrzonek P; Reisinger J
    BMJ Case Rep; 2012 Aug; 2012():. PubMed ID: 22927286
    [No Abstract]   [Full Text] [Related]  

  • 5. ST segment elevation in the right precordial leads induced with class IC antiarrhythmic drugs: insight into the mechanism of Brugada syndrome.
    Fujiki A; Usui M; Nagasawa H; Mizumaki K; Hayashi H; Inoue H
    J Cardiovasc Electrophysiol; 1999 Feb; 10(2):214-8. PubMed ID: 10090224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Life-threatening ventricular tachycardia during flecainide treatment for symptomatic atrial fibrillation in a patient with a structural cardiac disorder].
    Rienstra M; Wiesfeld AC; van Veldhuisen DJ; van Gelder IC
    Ned Tijdschr Geneeskd; 2006 May; 150(18):1027-31. PubMed ID: 16715868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paroxysmal Atrial Fibrillation on Flecainide Therapy.
    Gavin JL; Peigh GS; Kim SS
    Eur J Intern Med; 2020 Nov; 81():89-90. PubMed ID: 32980218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tachycardia due to atrial flutter with rapid 1:1 conduction following treatment of atrial fibrillation with flecainide.
    Taylor R; Gandhi MM; Lloyd G
    BMJ; 2010 Mar; 340():b4684. PubMed ID: 20219811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case of flecainide-induced hyponatremia.
    Ahmed M; Sra J; Akhtar M; Mortada ME
    J Cardiovasc Electrophysiol; 2009 Oct; 20(10):1170-2. PubMed ID: 19298558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The safety of flecainide treatment of atrial fibrillation: long-term incidence of sudden cardiac death and proarrhythmic events.
    Almroth H; Andersson T; Fengsrud E; Friberg L; Linde P; Rosenqvist M; Englund A
    J Intern Med; 2011 Sep; 270(3):281-90. PubMed ID: 21635583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flecainide for supraventricular tachyarrhythmias.
    Med Lett Drugs Ther; 1992 Jul; 34(875):71-2. PubMed ID: 1630411
    [No Abstract]   [Full Text] [Related]  

  • 12. Cardiac devices with class 1C antiarrhythmics: a potentially toxic combination.
    Apps A; Miller CP; Fellows S; Jones M
    BMJ Case Rep; 2015 Aug; 2015():. PubMed ID: 26286909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Paroxysmal atrial fibrillation: which patients need anti-arrhythmia drugs?. Interview by Dr. med. Ulrike Hennemann].
    Meinertz T
    Fortschr Med; 1996 Aug; 114(24):42-3. PubMed ID: 8974971
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical case of the month. Atrial flutter with rapid ventricular response (1:1 atrioventricular conduction) caused by flecaïnide].
    Robinet S; Melon R; Piérard L
    Rev Med Liege; 2007 Dec; 62(12):701-3. PubMed ID: 18286943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flecainide.
    Ector H
    Acta Cardiol; 2011 Apr; 66(2):247-8. PubMed ID: 21591585
    [No Abstract]   [Full Text] [Related]  

  • 16. [Interstitial pneumopathy due to flecainide].
    Haas M; Pérault MC; Bonnefoy P; Rodeau F; Caron F
    Presse Med; 2001 Jun 16-23; 30(21):1062. PubMed ID: 11471279
    [No Abstract]   [Full Text] [Related]  

  • 17. Failure of diltiazem to prevent 1:1 conduction of atrial flutter: a case report.
    Tiver KD; Martin DK; Quah J; Lahiri A; Ganesan AN
    J Med Case Rep; 2023 Jul; 17(1):319. PubMed ID: 37464369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flecainide as first-line treatment for supraventricular tachycardia in newborns.
    Ferlini M; Colli AM; Bonanomi C; Salvini L; Galli MA; Salice P; Ravaglia R; Centola M; Danzi GB
    J Cardiovasc Med (Hagerstown); 2009 May; 10(5):372-5. PubMed ID: 19300276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Infusion of flecainide in a patient with atrial fibrillation and latent Brugada's syndrome has determined modifications of the electrocardiogram similar to those of a septal myocardial infarct].
    Vitiello N; Cirillo R; Fontana D; Granato L; Sestri C; Pagano V; D'Errico L; Carotenuto F; di Palma F
    Ital Heart J Suppl; 2003 Feb; 4(2):128-32. PubMed ID: 12762263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does a Brugada pattern ECG precipitated by excessive-dose flecainide provide a diagnosis of a Brugada syndrome patient and/or contraindicate its use? A case study.
    Reiffel JA
    Circ Arrhythm Electrophysiol; 2011 Aug; 4(4):e47-51. PubMed ID: 21846883
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.